The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Non-Malignant Channel is supported with funding from Agios (Gold).
The Sickle Cell Disease Channel is supported with funding from Agios (Gold).
The Thalassemia Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESH Erythro 2025 | Managing adult patients with thalassemia: the value of a multidisciplinary approach
Perla Eleftheriou, MRCP, FRCpath, University College London Hospitals NHS Foundation Trust, London, UK, comments on the importance of a multidisciplinary approach when managing adult patients with thalassemia, highlighting the need for regular monitoring of transfusion regimens, iron overload, cardiac function, and endocrine health, as well as close collaboration with specialists from various fields. Dr Eleftheriou emphasizes the value of involving patients in the decision-making process and working closely with patient societies to increase awareness of research and novel treatments. This interview took place at the 4th ESH Translational Research Conference on Pathophysiology and Clinical Advances in Sickle Cell Disease and Thalassemia in Dublin, Ireland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
